» Articles » PMID: 32974691

A DELPHI Consensus Statement on Antiplatelet Management for Intracranial Stenting Due to Underlying Atherosclerosis in the Setting of Mechanical Thrombectomy

Abstract

Purpose: There is little data and lack of consensus regarding antiplatelet management for intracranial stenting due to underlying intracranial atherosclerosis in the setting of endovascular treatment (EVT). In this DELPHI study, we aimed to assess whether consensus on antiplatelet management in this situation among experienced experts can be achieved, and what this consensus would be.

Methods: We used a modified DELPHI approach to address unanswered questions in antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of EVT. An expert-panel (19 neurointerventionalists from 8 countries) answered structured, anonymized on-line questionnaires with iterative feedback-loops. Panel-consensus was defined as agreement ≥ 70% for binary closed-ended questions/≥ 50% for closed-ended questions with > 2 response options.

Results: Panel members answered a total of 5 survey rounds. They acknowledged that there is insufficient data for evidence-based recommendations in many aspects of antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of EVT. They believed that antiplatelet management should follow a standardized regimen, irrespective of imaging findings and reperfusion quality. There was no consensus on the timing of antiplatelet-therapy initiation. Aspirin was the preferred antiplatelet agent for the peri-procedural period, and oral Aspirin in combination with a P2Y12 inhibitor was the favored postprocedural regimen.

Conclusion: Data on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of EVT are limited. Panel-members in this study achieved consensus on postprocedural antiplatelet management but did not agree upon a preprocedural and intraprocedural antiplatelet regimen. Further prospective studies to optimize antiplatelet regimens are needed.

Citing Articles

Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke.

Latacz P, Popiela T, Brzegowy P, Lasocha B, Kwiecien K, Simka M Neurol Int. 2024; 16(1):253-262.

PMID: 38392958 PMC: 10892545. DOI: 10.3390/neurolint16010017.


What is a Challenging Clot? : A DELPHI Consensus Statement from the CLOTS 7.0 Summit.

Ospel J, Mirza M, Clarencon F, Siddiqui A, Doyle K, Consoli A Clin Neuroradiol. 2023; 33(4):1007-1016.

PMID: 37284876 DOI: 10.1007/s00062-023-01301-2.


Comparison of Safety and Efficacy after Emergency Stenting in Patients Exhibiting Intracranial Atherosclerotic Stenosis Associated with Large-vessel Occlusion with and without Intravenous Infusion of Tirofiban.

Garayzade R, Berlis A, Schiele S, Schneider H, Ertl M, Muller G Cardiovasc Intervent Radiol. 2023; 46(3):377-384.

PMID: 36797426 PMC: 10014670. DOI: 10.1007/s00270-023-03372-7.


Outcomes in acute ischemic stroke patients undergoing endovascular thrombectomy: Cervical internal carotid artery pseudo-occlusion vs. true occlusion.

Ni H, Yang T, Jia Z, Shi H, Liu S, Zhao L Front Neurol. 2023; 13:1106358.

PMID: 36698876 PMC: 9868848. DOI: 10.3389/fneur.2022.1106358.


Evidence-Based Updates to Thrombectomy: Targets, New Techniques, and Devices.

Yeo L, Jing M, Bhogal P, Tu T, Gopinathan A, Yang C Front Neurol. 2021; 12:712527.

PMID: 34566856 PMC: 8459011. DOI: 10.3389/fneur.2021.712527.


References
1.
Filippi M, Rocca M, Ciccarelli O, De Stefano N, Evangelou N, Kappos L . MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016; 15(3):292-303. PMC: 4760851. DOI: 10.1016/S1474-4422(15)00393-2. View

2.
Meves S, Neubauer H, Overbeck U, Endres H . Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry. BMC Res Notes. 2011; 4:106. PMC: 3088887. DOI: 10.1186/1756-0500-4-106. View

3.
Baek J, Kim B, Heo J, Kim D, Nam H, Kim Y . Outcomes of Endovascular Treatment for Acute Intracranial Atherosclerosis-Related Large Vessel Occlusion. Stroke. 2018; 49(11):2699-2705. DOI: 10.1161/STROKEAHA.118.022327. View

4.
Chang Y, Kim B, Bang O, Baek J, Heo J, Nam H . Rescue Stenting for Failed Mechanical Thrombectomy in Acute Ischemic Stroke: A Multicenter Experience. Stroke. 2018; 49(4):958-964. DOI: 10.1161/STROKEAHA.117.020072. View

5.
Nappini S, Limbucci N, Leone G, Rosi A, Renieri L, Consoli A . Bail-out intracranial stenting with Solitaire AB device after unsuccessful thrombectomy in acute ischemic stroke of anterior circulation. J Neuroradiol. 2018; 46(2):141-147. DOI: 10.1016/j.neurad.2018.05.004. View